Cidara Therapeutics, Inc.

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 6310 NANCY RIDGE DRIVE, SAN DIEGO, CA, 92121
Mailing Address 6310 NANCY RIDGE DRIVE, SAN DIEGO, CA, 92121
Phone 858-752-6170
Fiscal Year End 1231
EIN 461537286

Financial Overview

FY2024 FY

$23.28M
Revenue
-$22.93M
Net Income

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment February 13, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) January 30, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment January 9, 2026 View on SEC
4 Insider stock transaction report January 9, 2026 View on SEC
4 Insider stock transaction report January 7, 2026 View on SEC
4 Insider stock transaction report January 7, 2026 View on SEC
4 Insider stock transaction report January 7, 2026 View on SEC
4 Insider stock transaction report January 7, 2026 View on SEC
4 Insider stock transaction report January 7, 2026 View on SEC
8-K Current report of material events January 7, 2026 View on SEC

Insider Trading

SELL 1 insiders 1 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.